Status: Not yet recruiting
Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B
This is a multicenter, randomized, placebo-controlled (double-blind design) versus active-controlled (open-label design) Phase I clinical trial evaluating the efficacy and safety of TVAX-008 injection in subjects with chronic hepatitis B.
Participants needed: 630
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd.Updated: Dec 15, 2025
Eligibility criteria
Male or female, aged 18 to 65 years (inclusive); [+6]
Liver disease caused by other causes, including alcoholic liver disease, nonalco... [+26]